Investor name:
Christopher Gagliardi
Investor type:
Locations:
Social media:
Available after registration.Past investments:
- Proteostasis Therapeutics
- Science 37
- ImmuneXcite
- Aetion
- NeuroVia
- Medisafe
- Lysosomal Therapeutics
- Sirtris Pharmaceuticals
- UNUM Therapeutics
- Immune Design
- Common Sensing
- GlycoMimetics
- NGI
- Yumanity Therapeutics
- KAHR medical
- Kymera Therapeutics
- Ovid Therapeutics
- Expansion Therapeutics
- Imbria Pharmaceuticals
- Cogent Biosciences
- Bluebird Bio
- Abcuro
- NodThera
- Fate Therapeutics
- Minervax
- Omada Health
- Selecta Biosciences
- Edimer Pharmaceuticals
- Icosavax
- Navitor Pharmaceuticals
- DiCE Molecules
- Escient Pharmaceuticals
- Evidation Health
- Curisium
- Click Therapeutics
- Q32 Bio
- Veralox Therapeutics
- Lumena Pharmaceuticals
- Lava Therapeutics
- Inozyme
- i2o Therapeutics
Finally raise your round with Angel Match
Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.
Find the perfect investors today